May 29th 2024
The treatment is the first liquid non-stimulant for attention deficit hyperactivity disorder to be approved in the United States.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Chronically Ill Kids More Vulnerable to Hospital Medical Errors
November 30th 2012Even after accounting for confounding variables such as disease severity and length of stay, pediatric inpatients with chronic conditions are significantly more likely to experience medical errors, according to the results of a study.
Read More